Thymulin is a Zn-bound nonapeptide produced by the thymic epithelial cells (TEC) whose secretion is modulated by growth hormone (GH), among others. We assessed the ability of thymulin to influence the release of GH from dispersed anterior pituitary (AP) cells from young, middle-aged and senescent Sprague-Dawley female rats. Perifused and incubated AP cells were used in different sets of experiments and GH release was measured by RIA. Perifusion of young and senescent AP cells with thymulin doses, ranging from 10–8 to 10–5 M, gave a logarithmic dose-response pattern of GH. Supernatants from TEC lines also showed GH secretagogue activity. The GH release was always lower in the senescent cells. AP cells incubated with 10–8–10–3 M thymulin showed a time- and dose-dependent response, the latter being bell-shaped with a maximum at 10–7 M thymulin. Preincubation of thymulin with an antithymulin serum completely quenched the secretagogue activity of the hormone. Coincubation of thymulin with GHRH revealed a semiadditive release of GH in young and middle-aged AP cells and an additive effect in senescent cells. In middle-aged AP cells, the synthetic GH secretagogue GHRP-6 showed a synergistic effect with thymulin on GH release. The calcium chelator EGTA, but not the calcium ionophore A23187, blocked the GH-releasing activity of thymulin in AP cells. The cAMP enhancers, caffeine, NaF and forskolin significantly increased the thymulin-stimulated release of GH while trifluoperazine, a protein kinase C inhibitor, had no effect. The inositol phosphate enhancer LiCl potentiated the action of thymulin on GH release. The data suggest that the GH-releasing activity of thymulin is receptor-mediated and involves calcium, cAMP and inositol phosphates. In addition, senescence appears to impair somatotrope responsiveness to thymulin.

Keywords:
Thymulin, Somatotropes, Growth hormone, Cyclic AMP, Phosphoinositides, Calcium, Aging
1.
Bach JF: Thymulin (FTS-Zn) 1983. Clin Immunol Allergy 1983;3:133–156.
2.
Gastinel LN, Dardenne M, Pléau JM, Bach JF: Studies on the zinc binding site to the serum thymic factor. Biochim Biophys Acta 1984;797:147–155.
3.
Dardenne M, Pléau JM, Nabarra B, Lefrancier P: Contribution of zinc and other metals to the biological activity of serum thymic factor (FTS). Proc Natl Acad Sci USA 1982;79:5370–5373.
4.
Bach MA, Beaurain G: Respective influence of extrinsic and intrinsic factors on the age-related decrease of thymic secretion. J Immunol 1979;122:2505–2507.
5.
Savino W, Dardenne M, Bach JF: Thymic hormone containing cells. II. Evolution of cells containing the serum thymic factor (FTS or thymulin) in normal and autoimmune mice, as revealed by anti-FTS monoclonal antibodies. Relationship with Ia-bearing cells. Clin Exp Immunol 1983;52:1–6.
6.
Dardenne M, Bach MA, Bach JF: Thymic hormones and aging; in Fabris N (ed): Immunology and Aging. The Hague, Nijhoff, 1986, vol 3, pp 139–162.
7.
Savino W, Dardenne M, Bach JF: Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells. Clin Exp Immunol 1983;52:7–12.
8.
Cohen S, Berrih S, Dardenne M, Bach JF: Feed-back regulation of the secretion of a thymic hormone (thymulin) by human thymic epithelial cells in culture. Thymus 1986;8:109–119.
9.
Savino W, Dardenne M: Immune-neuroendocrine interactions. Immunol Today 1995;16:318–322.
10.
Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, Dardenne M: GH and IGF-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992;75:183–188.
11.
Ban E, Gagnerault MC, Jammes H, Postel-Vinay MC, Haour F, Dardenne M: Specific binding sites for growth hormone in cultured mouse thymic epithelial cells. Life Sci 1991;48:2141–2148.
12.
Goff BL, Roth JA, Arp LH, Incefy GS: Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 1987;68:580–587.
13.
Goya RG, Gagnerault MC, Leite de Moraes MC, Savino W, Dardenne M: In vivo effects of growth hormone on thymus function in aging mice. Brain Behav Immun 1992;6:341–354.
14.
Goya RG, Gagnerault MC, Sosa YE, Bevilacqua JA, Dardenne M: Effects of growth hormone and thyroxine on thymulin secretion in aging rats. Neuroendocrinology 1993;58:338–343.
15.
Mocchegiani E, Paolucci P, Balsamo A, Cacciari E, Fabris N: Influence of growth hormone on thymic endocrine activity in humans. Horm Res 1990;33:7–14.
16.
Goya RG, Sosa YE, Cónsole GM, Dardenne M: Altered thyrotropic and somatotropic responses to environmental challenges in congenitally athymic mice. Brain Behav Immun 1995;9:79–86.
17.
Lefrancier P, Derrien M, Amiot JL, Choay J: Large-scale synthesis of serum thymic factor (FTS) or thymulin; in Ragnarsson U (ed): Peptides. Stockholm, Almqvist & Wiksell, 1984, pp 251–254.
18.
Metreau E, Pléau JM, Dardenne M, Bach JF, Pradelles P: An enzyme immunoassay for synthetic thymulin. J Immunol Methods 1987;102:233–242.
19.
Bolzán AD, Bianchi MS, Cónsole GM, Goya RG: Relationship between pituitary hormones, antioxidant enzymes and histopathological changes in the mammary gland of senescent rats. Exp Gerontol 1997;32:297–304.
20.
Cónsole GM, Gómez Dumm CLA, Brown OA, Ferese C, Goya RG: Sexual dimorphism in the age changes of the pituitary lactotrophs in rats. Mech Ageing Dev 1997;95:157–166.
21.
Itoh T, Kasahara S, Mori T: A thymic epithelial cell line, IT-45R1, induces the differentiation of prethymic progenitor cells into post-thymic cells through direct contact. Thymus 1982;4:69–75.
22.
Cirne-Lima EO, Van Ewijk W, Savino W: A mouse thymic epithelial cell line bears simultaneously cortical and medullary cytokeratin-defined phenotypes. In Vitro Cell Dev Biol 1993;29A:443–445.
23.
Brunk CF, Jones KC, James TW: Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem 1978;92:497–500.
24.
Brown OA, Sosa YE, Goya RG: Histones as extracellular messengers: Effects on growth hormone secretion. Cell Biol Int 1997;21:787–792.
25.
Weiss J, Jameson JL: Perifused pituitary cells as a model for studies of gonadotropin biosynthesis and secretion. Trends Endocrinol Metab 1993;4:265–270.
26.
Stachura ME, Lapp CA, Tyler JM, Lee YS: Medium flow rate modulates autocrine-paracrine feedback of GH and PRL release by perifused GH3 cells. In Vitro Cell Dev Biol 1990;26:482–492.
27.
Zaidi SAA, Kendall MD, Gillham B, Jones MT: The release of LH from pituitaries perifused with thymic extracts. Thymus 1988;12:253–264.
28.
Hadley AJ, Rantle CM, Buckingham JC: Thymulin stimulates corticotropin release and cyclic nucleotide formation in the rat anterior pituitary gland. Neuroimmunomodulation 1997;4:62–69.
29.
Cónsole GM, Gómez Dumm CLA, Goya RG: Impact of ageing on the morphology and function of the somatotroph cell population in rats. Mech Ageing Dev 1993;70:45–51.
30.
McCann SM, Karanth S, Karmat A, Lysan K, Gimeno M, Rettori V: Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation 1994;1:2–13.
31.
Pléau JM, Fuentes V, Morgat JM, Bach JF: Specific receptor for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines. Proc Natl Acad Sci USA 1980:77:2861–2865.
32.
Gastinel LN, Pléau JM, Dardenne M: High affinity binding sites on plasma membrane obtained from the lymphoblastoid cultured 1301 cell line for highly radioactive serum thymic factor. Biochim Biophys Acta 1982;684:117–126.
33.
Frohman LA, Jason JO: Growth hormone-releasing hormone. Endocr Rev 1986;7:233–253.
34.
Chen C, Wu D, Clarke IJ: Signal transduction systems employed by synthetic GH-releasing peptides in somatotroph. J Endocr 1996;148:381–386.
35.
Bach MA, Bach JF: Studies on thymus products. VI. The effect of cyclic nucleotides and prostaglandins on rosette-forming cells. Interactions with thymic factors. Eur J Immunol 1973;3:778–783.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.